2022-03-30-上交所-健康元药业集团股份有限公司2021年社会责任报告（英文版）_69页_26mb

CSR Report Summary: Joincare Pharmaceutical Group 2021

Introduction and Mission

Joincare Pharmaceutical Group focuses on "For the Health, For the Future," aiming to develop high-quality and innovative medicines. In 2021, the company achieved significant financial growth with total revenues of RMB 15.904 billion, up 17.62 year-on-year, and won awards for social responsibility and rural revitalization.

Governance and Strategy

The company established a robust CSR governance structure, including a Board of Directors CSR Committee and a Social Responsibility Working Group. Key areas include compliance governance, anti-corruption mechanisms, and investor relations, ensuring regulatory adherence and ethical operations. The 2021 CSR Report was widely recognized, with Shanghai Stock Exchange rating "A" for transparency.

Product Quality and Innovation

Joincare prioritizes quality through full-lifecycle management, including R&D, production, and post-marketing surveillance. Innovations include inhalation preparations, biopharma, and sustained-release microspheres. The company obtained numerous patents and certifications, and implemented strict pharmacovigilance to ensure drug safety.

Healthcare Access and Sustainability

Efforts focus on respiratory and rare diseases, with products listed in national healthcare systems and central drug procurement. Joincare promotes rational medicine use through public education and advocates for affordable access, especially in developing regions. Sustainability initiatives include energy conservation, emission reductions, and waste management, aligned with national "dual carbon" goals.

Employee Empowerment

The company ensures labor rights, diverse hiring, and comprehensive training programs. Employee retention is strong, with a 16% turnover rate, supported by competitive compensation, equity incentives, and work-life balance activities like wellness programs and childcare facilities.

Environmental and Social Responsibility

Joincare addresses climate change through energy efficiency and greenhouse gas reductions. Environmental management includes ISO14001 certification, waste treatment, and clean production. Charitable activities involve public health programs, education support, and disaster relief, with total donations exceeding RMB 29 million in 2021.

Performance Highlights

Key metrics show steady growth in employee training hours and CSR compliance. Financial indicators include R&D investment at 11.63% of revenue and significant environmental investments, reinforcing Joincare's commitment to sustainable development.